Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a...
The American Diabetes Association® is pleased to announce this year's National Scientific and Health Care Achievement Award recipients. The awards...
Today, the American Diabetes Association® (ADA) announced the awardees of the Pathway to Stop Diabetes® (Pathway) grants. This year's grants dedicate ...
The American Diabetes Association® (ADA) welcomes the 2024 principal officers and board of directors. The 15-member board is comprised of...
Today, the American Diabetes Association® (ADA) released the Standards of Care in Diabetes—2024 (Standards of Care), a set of comprehensive and...
On this World Diabetes Day, the American Diabetes Association® (ADA), the world's leading diabetes organization, brings to light the "We Fight" theme....
Today, the American Diabetes Association® (ADA) published the Economic Costs of Diabetes in the U.S. in 2022 (Economic Report), a comprehensive...
The American Diabetes Association® (ADA), a sponsor of the 2023 Magic City Classic (MCC), and Genentech, anchor partner of the ADA's Health Equity...
The American Diabetes Association® (ADA) invites life science leaders, business professionals, angel investors and venture capitalists to the 28th...
Today, findings from two phase 2 clinical trials showcase new data for an investigational, once-weekly injectable glucose-dependent insulinotropic...
Today, findings from the COORDINATE-Diabetes trial demonstrated that multi-disciplinary care between cardiologists, diabetes specialists and other...
Late breaking data focused on new drug therapy innovations to treat obesity were presented at the American Diabetes Association's® (ADA) 83rd...
Today, the American Diabetes Association® (ADA) published updates in the Standards of Care in Diabetes—2023 (Standards of Care) based on the latest...
Today, the American Diabetes Association® (ADA) published updates to the Standards of Care in Diabetes—2023 (Standards of Care) on the use of...
Today, the American Diabetes Association® (ADA) announced the winner of its inaugural pitch competition at the 83rd Scientific Sessions of the...
Results from two studies evaluating the impact of mental health support for diabetes patients found significant benefits in patient outcomes were...
Today, the American Diabetes Association® (ADA) and Abbott announced a collaboration aimed at better understanding how diabetes technology like...
Today, a new trial revealed data on the effects of bempedoic acid – a non-statin cholesterol-lowering drug – on cardiovascular outcomes,...
Today, findings from two studies showcase groundbreaking technology and the latest diabetes developments related to glucose control and diabetic...
New research from the National Institutes of Health (NIH) found that blood glucose levels obtained at childhood examinations predicted future...
Today, findings from SURMOUNT-2, a study of tirzepatide in participants with type 2 diabetes who have obesity were announced, demonstrating more...
Today, findings from the ongoing clinical trial of VX-880, a phase 1/2, multi-center, single-arm, open-label study in patients with type 1 diabetes...
Today, the American Diabetes Association® (ADA) announced that it has received a $12.5 million grant from the Centers for Disease Control and...
On June 23, the American Diabetes Association® (ADA) will kick off the 83rd Scientific Sessions in San Diego, CA. The ADA's Scientific Sessions is...
Registration is open for the American Diabetes Association® (ADA) 2023 summer camp season. The ADA runs 33 camps located in 20 states throughout the...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.